CVS Health (CVS) Tops Q3 EPS by 8c; Confirmed Adjusted EPS guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $101.30 +3.03%
EPS Growth %: +1.1%
Financial Fact:
Income from continuing operations: 1.54B
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +1.1%
Financial Fact:
Income from continuing operations: 1.54B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q3 EPS of $2.21, $0.08 better than the analyst estimate of $2.13. Revenue for the quarter came in at $89.76 billion versus the consensus estimate of $88.29 billion.
GUIDANCE:
CVS Health sees FY2023 EPS of $8.50-$8.70, versus the consensus of $8.58. Revised GAAP diluted EPS guidance range to $6.37 to $6.61 from $6.53 to $6.75.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- NVE Corporation names new CEO and expands board to seven members
- C.H. Robinson acquires DeSpir Logistics for $75 million
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
